Tevogen Bio Is A Clinical Stage Specialty Immunotherapy Company Founded In 2020The Company Is Dedicated To Making Personalized Immunotherapies Accessible To Large Patient Populations By Utilizing Cd8Cytotoxic T Lymphocytestevogen Bio Aims To Be A Leader In Offering Economically Viable And Affordable Personalized T Cell Therapies For Various Health Conditionsincluding Infectious Diseasescancersand Neurological Disorders The Company Employs Its Exactcell Platform To Develop Off The Shelf Precision T Cell Therapieswhich Are Designed To Recognize And Attack Specific Pathological Markers Without Genetic Modificationtevogen Bio Also Integrates Advanced Biotechnology With Artificial Intelligence Through Its Tevogen Ai Initiativeenhancing Drug Discovery And Development Processesthe Leadership Team Includes Experienced Professionals From Diverse Backgroundscontributing To The Company S Innovative Approach In The Biopharmaceutical Sectortevogen Bio Began Public Trading On The Nasdaq Exchange Under The Ticker Symboltvgnin February 2024
No conferences found for this company.
| Company Name | Tevogen Bio Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
